Zeon Lifesciences has been awarded a new patent, "A Method for the Preparation of a Phyto-Product Using Plant Material." This patent represents a significant step forward in the realm of phytoproducts, showcasing Zeon's commitment to scientific research and the creation of novel natural solutions. 

The newly patented method focuses on extracting leaves and fruit from Annona muricata, a plant known for its strong anti-cancer capabilities. This innovative technology not only improves extraction efficiency but also preserves the bioactivity and integrity of phytoproducts, making it a significant breakthrough. 

Zeon Lifesciences' newest patented technology revolutionises the extraction of Annona muricata leaves and fruit by increasing yield while maintaining the compounds' inherent potency. This revolutionary approach guarantees a better level of purity and consistency, meeting the demanding quality criteria required for phytoproducts. Furthermore, multiple studies have proven that the approach retains the bioactive chemicals' powerful anti-cancer capabilities. 

Zeon Lifesciences is dedicated to furthering research in photoproduct development and diversifying its range. "We intend to expand our portfolio to include a broader range of plant-derived solutions, catering to the growing global demand for natural, sustainable, and efficacious products," stated Mr Suresh Garg, CMD and Founder of Zeon Lifesciences Ltd.

"Our capability to create customised formulations of this patented ingredient in tablet, capsule, and powder form ensures convenient dosage formats for diverse consumer needs," he added.

Looking ahead, Zeon Lifesciences is excited about the potential impact of this patented method on the industry. The company is committed to continuing its journey towards pioneering advances in photoproduct research and meeting the growing global need for natural and effective health solutions.